在肝脏和心脏以外的β-thalassemia患者的定量MRI铁负荷评估:系统性审查
Mustafa M Almuqbel1, Sarah Abousrafa1, Waad Omara1
1Department of Medical Radiography, College of Health Sciences, University of Doha for Science and Technology, Qatar.
European journal of radiology
|November 19, 2025
概括
磁共振成像 (MRI) 量化了血病患者的铁. 这次审查突出了T2*映射的重点.
科学领域:
- 放射学和医学成像学 医学成像学
- 血液学 血液学 血液学
- 生物医学工程 生物医学工程
背景情况:
- β-thalassemia 患者出现铁过载,需要精确的量化.
- 磁共振成像 (MRI) 是评估组织铁的关键非侵入性工具.
- 目前的MRI方法对肝脏和心脏的铁得到了验证,但对其他器官的验证较少.
研究的目的:
- 系统地审查量化MRI技术,以评估β-thalassemia患者的铁负荷.
- 为了确定特定器官的MRI铁量化方法的差距.
- 为了评估MRI的当前状态,以评估除肝脏和心脏之外的铁负担.
主要方法:
- 在MEDLINE,PubMed和Web of Science (过去10年) 的系统文献搜索.
- 纳入标准:量化MRI研究测量β-thalassemia患者的铁.
- 数据提取:患者详细信息,MRI序列,分析方法,临床相关性和诊断准确性.
主要成果:
- 27项研究评估了除了心脏和肝脏以外的器官中的铁.
- T2*加权的多回声梯度回声序列占主导地位 (86%).
- 基于兴趣区域 (ROI) 的T2*量化使用单指数拟合是常见的.
- 来自MRI的铁标记与内分泌/代谢功能障碍相关,但由于数据异质性,诊断性能相当好.
结论:
- T2*映射是铁量化所确立的非侵入性标准.
- 对于肝脏和心脏以外的器官,需要对MRI技术进行优化和标准化.
- 改进的方法将有助于早期检测和管理铁过载并发症.
相关概念视频
Imaging Studies for Cardiovascular System IV: CMRI
300
Cardiovascular magnetic resonance imaging, or CMRI, is a non-invasive diagnostic test that employs a magnetic field and radiofrequency waves to create precise images of the heart and arteries. It provides comprehensive information about cardiac anatomy, function, perfusion, and tissue characterization without ionizing radiation.IndicationsCMRI diagnoses various heart conditions, including tissue damage from heart attacks, ischemic heart disease, myocarditis, aortic issues (tears, aneurysms,...
300
Magnetic Resonance Imaging
9.0K
Magnetic resonance imaging (MRI) is a noninvasive medical imaging technique based on a phenomenon of nuclear physics discovered in the 1930s, in which matter exposed to magnetic fields and radio waves was found to emit radio signals. In 1970, a physician and researcher named Raymond Damadian noticed that malignant (cancerous) tissue gave off different signals than normal body tissue. He applied for a patent for the first MRI scanning device in clinical use by the early 1980s. The early MRI...
9.0K


